Affiliations 

  • 1 Family and Community Medicine Department, Chronic Diseases Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Electronic address: [email protected]
  • 2 Family and Community Medicine Department, Chronic Diseases Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Electronic address: [email protected]
  • 3 Family and Community Medicine Department, Chronic Diseases Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Electronic address: [email protected]
  • 4 Family and Community Medicine Department, Chronic Diseases Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Electronic address: [email protected]
  • 5 Family and Community Medicine Department, Chronic Diseases Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Electronic address: [email protected]
  • 6 Family and Community Medicine Department, Chronic Diseases Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Electronic address: [email protected]
  • 7 Discipline of Social and Administrative Pharmacy, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia. Electronic address: [email protected]
  • 8 Family and Community Medicine Department, Chronic Diseases Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Electronic address: [email protected]
  • 9 Family and Community Medicine Department, Chronic Diseases Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Electronic address: [email protected]
  • 10 Family and Community Medicine Department, Chronic Diseases Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Electronic address: [email protected]
  • 11 Department of Pharmacy Practice, College of Pharmacy, Qassim University, Qassim, Saudi Arabia. Electronic address: [email protected]
  • 12 Family and Community Medicine Department, Chronic Diseases Center, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Electronic address: [email protected]
Diabetes Metab Syndr, 2018 08 02;13(1):161-165.
PMID: 30641690 DOI: 10.1016/j.dsx.2018.07.012

Abstract

AIMS: To examine the impact of Ramadan Focused Education Program (RFEP) on medications adjustment in type 2 diabetes patients in Ramadan.

METHODS: This is a controlled, intervention based study. It was run on three phases: before, during, and after Ramadan on 262 type 2 diabetes patients. The intervention group (n = 140) received RFEP on medications doses & timing adjustment before and after Ramadan, while the control group (n = 122) received standard care.

RESULTS: The dose of insulin glargine was reduced from 42.51 ± 22.16 at the baseline to 40.11 ± 18.51-units during Ramadan (p = 0.002) in the intervention group while it remained the same in the control group before Ramadan and during Ramadan (38.51 ± 18.63 and 38.14 ± 18.46, P = 0.428, respectively). The hypoglycemia score was 14.2 ± (8.5) pre-Ramadan in the intervention and reduced to 6.36 ± 6.17 during Ramadan (p 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.